1,362
Participants
Start Date
December 1, 2017
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
hemoperfusion combined with hemodialysis
Hemoperfusion combined with hemodialysis treatment will perform at least once every two week. The hemoperfusion apparatus will use type HA130 resin hemoperfusion apparatus (Zhuhai Jafron Biomedical Co., Ltd, China)
hemodialysis
Blood purification (including low-flux hemodialysis, high-flux hemodialysis, or hemodiafiltration) treatment ≥10 hours per week
Changhai Hospital, Shanghai
Longhua Hospital Shanghai University of Traditional Chinese Medicine, Shanghai
RenJi Hospital, Shanghai
Ruijin Hospital, Shanghai
Shanghai 6th People's Hospital, Shanghai
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University, Shanghai
Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai
Shanghai Zhongshan Hospital, Shanghai
Yangpu District Central Hospital Affiliated to Tongji University, Shanghai
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Shanghai Zhongshan Hospital
OTHER
RenJi Hospital
OTHER
Ruijin Hospital
OTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
OTHER
Shanghai 6th People's Hospital
OTHER
Changhai Hospital
OTHER
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
OTHER
Shanghai University of Traditional Chinese Medicine
OTHER
Shanghai Tongji Hospital, Tongji University School of Medicine
OTHER
Yangpu District Central Hospital Affiliated to Tongji University
OTHER
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
OTHER